companydata.dkcompanydata.dk

CEPHALON FINLAND A/S: Financial statements 2025

CVR: 29245037

Source: annual report 2025, Danish Business Authority

01/01/2025 – 31/12/2025

CEPHALON FINLAND A/S (CVR 29245037) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK 7,078,554 and a net result of DKK 2,059,375 compared with DKK 296,806 the year before. That is an increase of 78.3% compared with the year before. Equity in the 2025 report amounted to DKK 7,193,391. The solvency ratio was 55.4%. The company had 5 employees in the financial year.

Gross Profit
DKK 7,078,554
Profit/Loss
DKK 2,059,375
Equity
DKK 7,193,391
Total Assets
DKK 12,983,483
Employees
5

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2025-7.1M2.1M7.2M5
2024-4M297K5.4M5
2023-4.2M521K5.1M5
2022-7M2.2M6.9M5
2021-5.8M1.3M6M6

Official annual report

View the official annual report directly on the page with a Pro subscription.

How creditworthy is CEPHALON FINLAND A/S?

See the CDS score and get a full credit report with recommended credit limit and payment terms.

Read about the CDS score

Events in 2025

CEPHALON FINLAND A/S: The 2024 annual report is outApr 7, 2025

CEPHALON FINLAND A/S has published its annual report for 2024. Gross profit came to DKK 3,970,317, and the net result was DKK 296,806.

About CEPHALON FINLAND A/S

CEPHALON FINLAND A/S is a Danish company of the type Aktieselskab based in Nørresundby, founded in 2006. The company is registered under the industry Engroshandel med læge- og hospitalsartikler. The management consists of Rolf Nejsum. The board consists of Bjørn Helmer Johnsen (chair), Rolf Nejsum and Vesa Antero Toropainen. The company is owned by Scanmed AS Norway. The company has 0 employees (2017). In 2025, the company reported a gross profit of DKK 7,078,554 and a net result of DKK 2,059,375 compared with DKK 296,806 the year before. Equity in the 2025 report amounted to DKK 7,193,391.

Source: annual report 2025, Danish Business Authority